CARY, N.C., Feb. 12, 2021 (SEND2PRESS NEWSWIRE) — Rescindo Therapeutics Inc., a drug discovery company dedicated to the development of new treatments for rare genetic disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation and Rare Pediatric Disease Designation for the Company’s lead drug RSC-57, for the treatment […]
Archive | Drugs and Pharmaceuticals
Press Release: Kalyagen Announces Launch of ‘Stem the Tide of Time’ Campaign Featuring NBA Hall of Fame Finalist Marques Johnson
By Send2Press Newswire on February 8, 2021 in Advertising and Marketing, AUSTIN, Texas, Business, Drugs and Pharmaceuticals, Press Releases
AUSTIN, Texas, Feb. 8, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen is pleased to announce the launch of its “Stem the Tide of Time” social media campaign featuring former UCLA Bruin and Milwaukee Buck All-Star Marques Johnson to promote STEMREGEN;, a natural stem cell enhancer documented to increase the number of circulating stem cells by stimulating Endogenous […]
Press Release: Kalyagen™ Announces Launch of Clinical Trial to Evaluate STEMREGEN® and Stem Cells for Advanced Heart Failure Patients
By Send2Press Newswire on February 5, 2021 in AUSTIN, Texas, Business, Drugs and Pharmaceuticals, Press Releases
AUSTIN, Texas, Feb. 5, 2021 (SEND2PRESS NEWSWIRE) — Kalyagen™, along with the Sociedad Espanola de Medicina Regenerativa y Terapia Celular (the “Spanish Society of Regenerative Medicine and Cell Therapy”), is pleased to announce the launch of a multicenter clinical trial, “The Effect of Stemregen and Adipose Stroma Vascular Fraction (SVF) Either Individually or in Combination […]
Press Release: EPIC Insurance Brokers & Consultants Acquires Pharmaceutical Strategies Group
By Send2Press Newswire on February 4, 2021 in Business, Drugs and Pharmaceuticals, Finance, Insurance, Mergers and Acquisitions, Press Releases, SAN FRANCISCO, Calif.
SAN FRANCISCO, Calif., Feb. 4, 2021 (SEND2PRESS NEWSWIRE) — EPIC Holdings, Inc. (EPIC) announced today that it has agreed to acquire Pharmaceutical Strategies Group (PSG). The move incorporates the expertise and resources of the nation’s largest independent pharmacy benefit consulting firm into EPIC’s Employee Benefits Consulting practice.